Effects of simvastatin on proinflammatory cytokines and matrix metalloproteinases in hypercholesterolemic individuals

Inflammation

Volumn 34, Issue 4, 2011, Pages 225-230

  Nilsson, Lennart ^a   Eriksson, Per ^b   Cherfan, Pierre ^c   Jonasson, Lena ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Hogland Hospital   (Sweden)

Author keywords

cytokine; hypercholesterolemia; matrix metalloproteinase; pleiotropic effects; statin

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; PLACEBO; SIMVASTATIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE RELEASE; DRUG RESPONSE; EX VIVO STUDY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CHOLESTEROL; CYTOKINES; HUMANS; HYPERCHOLESTEROLEMIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; SIMVASTATIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 79961172292     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9227-y     Document Type: Article

References (40)

1. PK Shah 2003 Mechanisms of plaque vulnerability and rupture Journal of the American College of Cardiology 41 5S 22S 10.1016/S0735-1097(02)02834-6
2. GK Hansson 2005 Inflammation, atherosclerosis, and coronary artery disease New England Journal Medicine 352 1685 1695 10.1056/NEJMra043430 1:CAS:528:DC%2BD2MXjsFCltrc%3D (Pubitemid 40530235)
3. J Frostegård AK Ulfgren P Nyberg U Hedin J Swedenborg U Andersson GK Hansson 1999 Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 145 33 43 10428293 10.1016/S0021-9150(99)00011-8 (Pubitemid 29292698)
4. W Koenig N Khuseyinova 2007 Biomarkers of atherosclerotic plaque instability and rupture Arteriosclerosis, Thrombosis, and Vascular Biology 27 15 26 17082488 10.1161/01.ATV.0000251503.35795.4f 1:CAS:528:DC%2BD28XhtlSrsb7I (Pubitemid 46360377)
5. ZS Galis GK Sukhova M Lark P Libby 1994 Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques Journal of Clinical Investigation 94 2493 2503 7989608 10.1172/JCI117619 1:CAS:528:DyaK2MXisFWgsrg%3D (Pubitemid 24379627)
6. ZS Galis GK Sukhova R Kranzhofer S Clark P Libby 1995 Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases Proceedings of the National Academy of Sciences of the United States of America 92 402 406 7831299 10.1073/pnas.92.2.402 1:CAS:528: DyaK2MXjt12qsLY%3D
7. H Kai H Ikeda H Yasukawa M Kai Y Seki F Kuwahara T Ueno K Sugi T Imaizumi 1998 Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes Journal of the American College of Cardiology 32 368 372 9708462 10.1016/S0735-1097(98)00250-2 1:STN:280: DyaK1cznt1WltQ%3D%3D (Pubitemid 28396484)
8. MH Tayebjee GY Lip KT Tan JV Patel EA Hughes RJ MacFadyen 2005 Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease The American Journal of Cardiology 96 339 345 16054454 10.1016/j.amjcard.2005.03.072 1:CAS:528:DC%2BD2MXmvVWlsbY%3D (Pubitemid 41058855)
9. D Fukuda K Shimada A Tanaka T Kusuyama H Yamashita S Ehara Y Nakamura T Kawarabayashi H Iida M Yoshiyama J Yoshikawa 2006 Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris The American Journal of Cardiology 97 175 180 16442358 10.1016/j.amjcard.2005.08.020 1:CAS:528:DC%2BD28Xos1Wiug%3D%3D (Pubitemid 43139231)
10. L Nilsson L Jonasson J Nijm A Hamsten P Eriksson 2006 Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease Clinical Chemistry 52 1522 1527 16762997 10.1373/clinchem.2006.067439 1:CAS:528:DC%2BD28XnvFaht7s%3D (Pubitemid 44148315)
11. S Blankenberg HJ Rupprecht O Poirier C Bickel M Smieja G Hafner J Meyer F Cambien L Tiret AtheroGene Investigators 2003 Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 1579 1585 12668489 10.1161/01.CIR. 0000058700.41738.12 1:CAS:528:DC%2BD3sXit12msLo%3D (Pubitemid 36397324)
12. E Lubos R Schnabel HJ Rupprecht C Bickel CM Messow S Prigge F Cambien L Tiret T Münzel S Blankenberg 2006 Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: Results from the AtheroGene study European Heart Journal 27 150 156 16230310 10.1093/eurheartj/ehi582 1:CAS:528:DC%2BD28XhsVegtbo%3D (Pubitemid 43069030)
13. P Garvin L Nilsson J Carstensen L Jonasson M Kristenson 2008 Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population PLoS ONE 12 3 1774 10.1371/journal.pone.0001774 (Pubitemid 351917339)
14. TC Wu HB Leu WT Lin CP Lin SJ Lin JW Chen 2005 Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease European Journal of Clinical Investigation 35 537 545 16128859 10.1111/j.1365-2362.2005.01548.x 1:CAS:528:DC%2BD2MXhtV2is7bJ (Pubitemid 41243296)
15. ZS Galis M Muszynski GK Sukhova E Simon-Morrissey EN Unemori MW Lark E Amento P Libby 1994 Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion Circulation Research 75 181 189 8013077 1:CAS:528:DyaK2cXltlait74%3D (Pubitemid 24187750)
16. TB Rajavashisth 1999 Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques. Evidence for activation by proinflammatory mediators Circulation 99 3103 3109 10377072 1:CAS:528:DyaK1MXktlSisbw%3D (Pubitemid 29289074)
17. DA Siwik DLF Chang WS Colucci 2000 Interleukin-1b and tumor necrosis factor-a decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro Circulation Research 86 1259 1265 10864917 1:CAS:528:DC%2BD3cXks1Kmt74%3D (Pubitemid 30436667)
18. P Ferroni S Basili F Martini CM Cardarello F Ceci M Di Franco G Bertazzoni PP Gazzaniga C Alessandri 2003 Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation Journal of Investigative Medicine 51 295 300 14577520 10.2310/6650.2003.3563 1:CAS:528:DC%2BD3sXoslyhurw%3D (Pubitemid 37210891)
19. C Baigent A Keech PM Kearney L Blackwell G Buck C Pollicino A Kirby T Sourjina R Peto R Collins R Simes Cholesterol Treatment Trialists' (CTT) Collaborators 2005 Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267 1278 16214597 10.1016/S0140-6736(05)67394-1 1:CAS:528:DC%2BD2MXhtVOlu7fM (Pubitemid 41416582)
20. BR Kwak F Mulhaupt F Mach 2003 Atherosclerosis: Anti-inflammatory and immunomodulatory activities of statins Autoimmunity Review 2 332 338 10.1016/S1568-9972(03)00049-1 1:CAS:528:DC%2BD3sXps12rsLk%3D (Pubitemid 37211387)
21. S Bellosta D Via M Canavesi P Pfister R Fumagalli R Paoletti F Bernini 1998 HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages Arteriosclerosis, Thrombosis, and Vascular Biology 18 1671 1678 9812903 1:CAS:528:DyaK1cXnvFShsbo%3D (Pubitemid 28521054)
22. Y Fukumoto P Libby E Rabkin CC Hill M Enomoto Y Hirouchi M Shiomi M Aikawa 2001 Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits Circulation 103 993 999 11181475 1:CAS:528:DC%2BD3MXit1Cqs7s%3D (Pubitemid 32183806)
23. GK Sukhova JK Williams P Libby 2002 Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol Arteriosclerosis, Thrombosis, and Vascular Biology 22 1452 1458 12231565 10.1161/01.ATV.0000030360.72503.56 1:CAS:528:DC%2BD38XntVKktbk%3D
24. B Voleti A Agrawal 2006 Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist Molecular Immunology 43 891 896 16054696 10.1016/j.molimm.2005.06.045 1:CAS:528:DC%2BD2MXhtlertL%2FO (Pubitemid 41814407)
25. R Hakamada-Taguchi Y Uehara K Kuribayashi A Numabe K Saito H Negoro T Fujita T Toyo-oka T Kato 2003 Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development Circulation Research 93 948 956 14563711 10.1161/01.RES.0000101298.76864.14 1:CAS:528:DC%2BD3sXoslykur8%3D (Pubitemid 37441285)
26. PM Ridker N Rifai MA Pfeffer F Sacks E Braunwald 1999 Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 230 235 10411845 1:CAS:528:DyaK1MXltVOhtrc%3D (Pubitemid 29340127)
27. I Jialal D Stein D Balis SM Grundy B Adams-Huet S Devaraj 2001 Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels Circulation 103 1933 1035 11306519 1:CAS:528:DC%2BD3MXjslKks7Y%3D
28. O Wiklund L Mattsson-Hultén E Hurt-Camejo J Oscarsson 2002 Effects of simvastatin and atorvastatin on inflammation markers in plasma Journal of Internal Medicine 251 338 347 11952885 10.1046/j.1365-2796.2002.00966.x 1:CAS:528:DC%2BD38Xjs1Kisr0%3D (Pubitemid 34592108)
29. W März K Winkler M Nauck BO Böhm BR Winkelmann 2003 Effects of statins on C-reactive protein and Interleukin-6 (The Ludwigshafen Risk and Cardiovascular Health Study) The American Journal of Cardiology 92 305 308 12888140 10.1016/S0002-9149(03)00633-7 (Pubitemid 36897718)
30. M Crisby G Nordin-Fredriksson PK Shah J Yano J Zhu J Nilsson 2001 Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization Circulation 103 926 933 11181465 1:CAS:528:DC%2BD3MXit1Cru70%3D (Pubitemid 32183796)
31. KK Koh JW Son JY Ahn DK Jin HS Kim YM Choi DS Kim 2002 Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease Arteriosclerosis, Thrombosis, and Vascular Biology 22 e19 e23 12231575 10.1161/01.ATV.0000030997. 02059.BB
32. Y Noji T Higashikata A Inazu A Nohara K Ueda S Miyamoto K Kajinami T Takegoshi J Koizumi H Mabuchi Hokuriku NK-104 Study Group 2002 Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia Atherosclerosis 163 157 164 12048134 10.1016/S0021-9150(01)00765-1 1:CAS:528:DC%2BD38XktFOns7s%3D (Pubitemid 34615738)
33. JW Son KK Koh JY Ahn DK Jin GS Park DS Kim EK Shin 2003 Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease International Journal of Cardiology 88 77 82 12659988 10.1016/S0167-5273(02)00368-6 (Pubitemid 36351413)
34. A Link T Ayadhi M Böhm G Nickenig 2006 Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome European Heart Journal 27 2945 2955 17012299 10.1093/eurheartj/ehl277 1:CAS:528:DC%2BD2sXhtFWksbo%3D (Pubitemid 44950437)
35. P Cherfan A Tompa LS WikbyA L Jonasson 2007 Effects of simvastatin on human T cells in vivo Atherosclerosis 193 186 192 16860807 10.1016/j. atherosclerosis.2006.06.022 1:CAS:528:DC%2BD2sXlvFamt7k%3D (Pubitemid 46779120)
36. A Meisser M Cohen P Bischof 2005 Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection Clinical Chemistry 51 274 276 15613733 10.1373/clinchem. 2004.041707 1:CAS:528:DC%2BD2MXlt1yruw%3D%3D (Pubitemid 40024062)
37. C Arnaud F Burger S Steffens NR Veillard TH Nguyen D Trono F Mach 2005 Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: New evidence for direct anti-inflammatory effects of statins Arteriosclerosis, Thrombosis, and Vascular Biology 25 1231 1236 15790934 10.1161/01.ATV. 0000163840.63685.0c 1:CAS:528:DC%2BD2MXksVWqsb4%3D (Pubitemid 40776614)
38. A Kalela R Laaksonen T Lehtimäki TA Koivu M Höyhtyä T Janatuinen P Pöllänen 2001 Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases The American Journal of Cardiology 88 173-175 A6
39. J Malik T Stulc R Ceska 2005 Matrix metalloproteinases in isolated hypercholesterolemia International Angiology 24 300 303 16158043 1:STN:280:DC%2BD2Mvos12msg%3D%3D (Pubitemid 41582341)
40. CY Huang TC Wu WT Lin HB Leu CP Lin SJ Lin JW Chen 2006 Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients European Journal of Clinical Investigation 36 76 84 16436088 10.1111/j.1365-2362.2006.01598.x 1:CAS:528:DC%2BD28XjtFegurw%3D